Pharmaceutical Executive-08-01-2007

News Analysis
Pharmaceutical Executive

August 01, 2007

Novartis' Zelnorm is back, but only through a restricted-access program.

News Analysis
Pharmaceutical Executive

August 01, 2007

A new study says obesity is like a social virus, so why is the obesity-drug market just sitting there?